تاریخچه درآمد، سود و جریان نقد از صورتهای مالی رسمی.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
نمودارهای تعاملی و صورتهای مالی کامل ← مدل ارزشگذاری (DCF) ←
| صورت سود و زیان | TTM → 2026-04-30 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 | 2015-04-30 | 2014-04-30 | 2013-04-30 | 2012-04-30 | 2011-04-30 | 2010-04-30 | 2009-04-30 | 2008-04-30 | 2007-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| مجموع درآمد | $36.4B | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B | $30.1B | $28.9B | $30.6B | $30.0B | $29.7B | $28.8B | $20.3B | $17.0B | $16.6B | $16.2B | $15.9B | $15.8B | $14.6B | $13.5B | $12.3B |
| سود ناخالص | $23.6B | $23.6B | $21.9B | $21.1B | $20.5B | $21.5B | $19.6B | $19.5B | $21.4B | $20.9B | $20.4B | $19.7B | $14.0B | $12.7B | $12.5B | $12.3B | $11.8B | $11.8B | $11.1B | $10.1B | $9.1B |
| حاشیه سود ناخالص % | 65.0% | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% | 67.4% | 70.0% | 69.7% | 68.7% | 68.3% | 68.9% | 74.5% | 75.1% | 76.0% | 74.1% | 74.7% | 75.9% | 74.5% | 74.2% |
| سود عملیاتی (EBIT) | $6.5B | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B | $4.5B | $4.8B | $6.3B | $6.6B | $5.4B | $5.4B | $3.8B | $3.8B | $4.4B | $4.5B | $4.5B | $4.8B | $3.5B | $3.7B | $3.7B |
| حاشیه سود عملیاتی % | 17.8% | 17.8% | 17.8% | 15.9% | 17.6% | 18.1% | 14.9% | 16.6% | 20.5% | 22.2% | 18.1% | 18.6% | 18.6% | 22.4% | 26.5% | 27.7% | 28.0% | 30.3% | 23.7% | 27.0% | 30.4% |
| سود خالص | $4.8B | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B | $3.6B | $4.8B | $4.6B | $3.1B | $4.0B | $3.5B | $2.7B | $3.1B | $3.5B | $3.6B | $3.1B | $3.1B | $2.2B | $2.2B | $2.8B |
| حاشیه سود خالص % | 13.2% | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% | 12.3% | 13.2% | 18.0% | 20.9% | 22.4% | 19.4% | 19.6% | 14.9% | 16.5% | 22.8% |
| EBITDA | $9.7B | $9.8B | $9.2B | $8.2B | $8.7B | $8.8B | $7.5B | $7.8B | $9.3B | $9.5B | $8.6B | $8.5B | $5.5B | $4.9B | $5.5B | $5.3B | $4.9B | $5.1B | $3.5B | $3.8B | $4.3B |
| سود هر سهم (EPS) | $3.73 | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 | $2.48 | $2.41 | $3.02 | $3.37 | $3.41 | $2.86 | $2.79 | $1.93 | $1.95 | $2.41 |
| سهام منتشرشده (میلیون) | 1,288M | 1,288M | 1,290M | 1,330M | 1,333M | 1,351M | 1,354M | 1,351M | 1,358M | 1,368M | 1,391M | 1,426M | 1,109M | 1,014M | 1,028M | 1,060M | 1,082M | 1,109M | 1,126M | 1,142M | 1,162M |
منبع: گزارشهای عمومی شرکت (SEC). پیش از اتکا به هر رقم، آن را در SEC EDGAR بررسی کنید.
ترازنامهها، جریانهای نقدی، دادههای فصلی و نسبتهای مالی کامل در نمایشگر تعاملی MDT در دسترس است. /companies/us/MDT
اطلاعات این وبسایت صرفاً برای اهداف آموزشی و اطلاعرسانی است و توصیه سرمایهگذاری نیست. هیچ هدف قیمتی یا توصیهای منتشر نمیشود.
About TickerBase · Data methodology & sources · Privacy · Terms